TNF and breast cancer: Current evidence suggests that inflammatory cytokines, TNFα and IL-6, increase STS activity (57, 61), although this has been disputed by a study showing negative correlation between TNFα/IL-6 expression and STS expression in soft tissue breast cancer metastases and primary tumors (281).